Fangtian Fan

945 total citations
44 papers, 760 citations indexed

About

Fangtian Fan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fangtian Fan has authored 44 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Fangtian Fan's work include Lung Cancer Treatments and Mutations (9 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA modifications and cancer (6 papers). Fangtian Fan is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA modifications and cancer (6 papers). Fangtian Fan collaborates with scholars based in China and United States. Fangtian Fan's co-authors include Aiyun Wang, Hongyan Wu, Yin Lu, Zhaoguo Liu, Shizhong Zheng, Cunsi Shen, Liwei He, Tao Li, Yuping Liu and Junshan Ruan and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and European Journal of Pharmacology.

In The Last Decade

Fangtian Fan

42 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangtian Fan China 18 414 192 142 115 69 44 760
Shulong Jiang China 19 450 1.1× 216 1.1× 133 0.9× 85 0.7× 37 0.5× 55 880
Xiangzhong Zhao China 16 537 1.3× 188 1.0× 111 0.8× 83 0.7× 46 0.7× 45 858
Aranka Brockmueller Germany 19 530 1.3× 206 1.1× 163 1.1× 72 0.6× 53 0.8× 33 1.1k
Jiege Huo China 19 403 1.0× 147 0.8× 229 1.6× 99 0.9× 93 1.3× 56 836
Namrata Rastogi India 14 379 0.9× 135 0.7× 148 1.0× 68 0.6× 49 0.7× 20 706
Ying Hou China 17 441 1.1× 130 0.7× 77 0.5× 97 0.8× 51 0.7× 30 735
Nehal Gupta United States 12 479 1.2× 152 0.8× 168 1.2× 101 0.9× 32 0.5× 18 836
Joon‐Seok Choi South Korea 20 569 1.4× 114 0.6× 182 1.3× 80 0.7× 46 0.7× 50 990

Countries citing papers authored by Fangtian Fan

Since Specialization
Citations

This map shows the geographic impact of Fangtian Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangtian Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangtian Fan more than expected).

Fields of papers citing papers by Fangtian Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangtian Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangtian Fan. The network helps show where Fangtian Fan may publish in the future.

Co-authorship network of co-authors of Fangtian Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Fangtian Fan. A scholar is included among the top collaborators of Fangtian Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangtian Fan. Fangtian Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Chenming, et al.. (2025). OTSSP167 suppresses TNBC brain metastasis via ROS-driven P38/JNK and FAK/ERK pathways. European Journal of Pharmacology. 1004. 178017–178017.
4.
Qi, Yanan, et al.. (2024). Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects. Journal of Inflammation Research. Volume 17. 6603–6618. 10 indexed citations
5.
Li, Tao, et al.. (2024). Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1. Pharmacological Research. 201. 107091–107091. 1 indexed citations
6.
Wang, Ansheng, Fangtian Fan, Chao Li, et al.. (2023). MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1. Human Gene Therapy. 34(11-12). 540–553. 5 indexed citations
7.
Li, Yongping, et al.. (2023). Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor. European Journal of Pharmacology. 945. 175571–175571. 7 indexed citations
8.
Fan, Fangtian, et al.. (2021). Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones. Journal of Inflammation. 18(1). 23–23. 15 indexed citations
9.
Zhang, Yuhan, Yu Wang, Wei Gao, et al.. (2021). Experimental Study of Almonertinib Crossing the Blood-Brain Barrier in EGFR-Mutant NSCLC Brain Metastasis and Spinal Cord Metastasis Models. Frontiers in Pharmacology. 12. 750031–750031. 33 indexed citations
10.
Li, Shanshan, et al.. (2021). Baicalein-ameliorated cerebral ischemia-reperfusion injury dependent on calpain 1/AIF pathway. Bioscience Biotechnology and Biochemistry. 86(3). 305–312. 5 indexed citations
12.
Li, Yao, Hua Yu, Liyuan Tao, et al.. (2018). A spontaneous metastatic mathematical model in mice for screening anti-metastatic agents. Journal of Pharmacological and Toxicological Methods. 92. 57–66. 1 indexed citations
13.
Wu, Hongyan, Liwei He, Jingjing Shi, et al.. (2018). Resveratrol inhibits VEGF‐induced angiogenesis in human endothelial cells associated with suppression of aerobic glycolysis via modulation of PKM2 nuclear translocation. Clinical and Experimental Pharmacology and Physiology. 45(12). 1265–1273. 32 indexed citations
14.
He, Liwei, et al.. (2017). Resveratrol suppresses pulmonary tumor metastasis by inhibiting platelet-mediated angiogenic responses. Journal of Surgical Research. 217. 113–122. 19 indexed citations
15.
16.
Fan, Fangtian, Hongyan Wu, Zhaoguo Liu, et al.. (2016). Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 84. 1858–1864. 9 indexed citations
17.
Liu, Zhaoguo, Pingting Zhu, Yu Tao, et al.. (2015). Cancer-promoting effect of capsaicin on DMBA/TPA-induced skin tumorigenesis by modulating inflammation, Erk and p38 in mice. Food and Chemical Toxicology. 81. 1–8. 40 indexed citations
18.
Wu, Hongyan, Fangtian Fan, Zhaoguo Liu, et al.. (2015). Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway. Cancer Chemotherapy and Pharmacology. 76(2). 307–315. 17 indexed citations
19.
Shen, Cunsi, Siliang Wang, Yunlong Shan, et al.. (2014). Chemomodulatory efficacy of lycopene on antioxidant enzymes and carcinogen-induced cutaneum carcinoma in mice. Food & Function. 5(7). 1422–1431. 16 indexed citations
20.
Fan, Fangtian, Cunsi Shen, Li Tao, et al.. (2014). PKM2 Regulates Hepatocellular Carcinoma Cell Epithelial-mesenchymal Transition and Migration upon EGFR Activation. Asian Pacific Journal of Cancer Prevention. 15(5). 1961–1970. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026